Is SNSE or SPRB more undervalued in 2026?

CirclFi compares Sensei Biotherapeutics, Inc. (SNSE) and Spruce Biosciences, Inc. (SPRB) using 13 institutional-grade valuation models. SNSE has a Quality of Company score of 3.7/10 while SPRB scores 5.3/10.

Which is a better buy — SNSE or SPRB?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do SNSE and SPRB valuations compare?

SNSE at $21.14 and SPRB at $51.27 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

SNSE vs SPRB Valuation Comparison 2026 — Intrinsic Value Analysis

SNSE

Pharmaceutical Preparations

Sensei Biotherapeutics, Inc.

Quality

3.7

out of 10

Value Trap

LOW

Price

$21.14

Last close

Models

5/13

Active

SPRB

Pharmaceutical Preparations

Spruce Biosciences, Inc.

Quality

5.3

out of 10

Value Trap

LOW

Price

$51.27

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	SNSE Fair Value	SNSE Upside	SPRB Fair Value	SPRB Upside
Bayesian DCF	Intrinsic	$66.45	+214.3%	$21.55	-58.0%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$1.33	-95.1%	$0.71	-98.8%
Dynamic NAV	Asset-Based	—	—	$27.57	-46.2%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for SNSE vs SPRB — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

SNSE vs SPRB — Which Stock Is More Undervalued?

SPRB scores higher with a 5.3/10 quality rating vs SNSE's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Sensei Biotherapeutics, Inc. (SNSE) and Spruce Biosciences, Inc. (SPRB) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

SNSE currently trades at $21.14 with a QOC of 3.7/10, while SPRB trades at $51.27 with a QOC of 5.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).